Clinical Trial 49680

Pompano Beach, FL 33064


The purpose of this clinical study is to compare the effectiveness and safety of an investigational drug (lanifibranor, which will be given as an oral pill taken each day), as a potential long-term treatment option for those living with NASH and liver fibrosis stage 2 or 3.  Lanifibranor is a pan-peroxisome proliferator-activated receptor (PanPPAR) agonist, an investigational drug with the potential to address metabolic and histological aspects of NASH, including possible decrease in triglycerides and increase of HDL (good) cholesterol. 

You may be eligible to participate if you:  

• Are 18 years or older

• Have been diagnosed with  non-alcoholic steatohepatitis (NASH) with liver fibrosis




Qualified Participants May Receive:

Free medical check up and assessments

Compensation for time and travel

$150- $225 for each visit to study site

$500.00 for liver biopsy.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.